Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Shares Outstanding (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Shares Outstanding for 4 consecutive years, with $103.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.85% to $103.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.0 million through Dec 2025, up 1.85% year-over-year, with the annual reading at $103.0 million for FY2025, 1.85% up from the prior year.
  • Shares Outstanding for Q4 2025 was $103.0 million at Day One Biopharmaceuticals, roughly flat from $102.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $103.0 million in Q4 2025, with the low at $61.9 million in Q1 2022.
  • Average Shares Outstanding over 4 years is $87.7 million, with a median of $87.3 million recorded in 2023.
  • The sharpest move saw Shares Outstanding tumbled 81.94% in 2023, then soared 560.87% in 2024.
  • Over 4 years, Shares Outstanding stood at $73.5 million in 2022, then increased by 18.74% to $87.2 million in 2023, then increased by 15.92% to $101.1 million in 2024, then rose by 1.85% to $103.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $103.0 million, $102.7 million, and $102.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.